Jérôme Marzinski Appointed as Chief Executive Officer
- gdelacruz57
- Nov 9, 2022
- 1 min read
Oxford, UK, November 07, 2022 (B3C newswire) -- OxSonics Therapeutics, a clinical-stage company focused on transforming cancer treatment through SonoTran®, its ultrasound-based drug delivery platform, announces that it has appointed Jérôme Marzinski as its Chief Executive Officer with immediate effect.
Read full article here.
Comments